How Much Does a Personalized Cancer Vaccine Cost?
Personalized cancer vaccines -- also called neoantigen vaccines -- are custom-built immunotherapies designed from a patient's own tumor DNA. As of 2026, the total cost of treatment typically falls between $100,000 and $119,000, and is not covered by most health insurance plans. These therapies remain investigational under FDA oversight, and costs are borne primarily by patients and their families.
The expense is distributed across several phases: genomic sequencing of the tumor ($5,000-$11,000), computational neoantigen identification ($5,000-$15,000), GMP-grade vaccine manufacturing ($30,000-$50,000), clinical administration including physician fees ($15,000-$25,000), and long-term immune monitoring ($5,000-$15,000). Each phase involves specialized laboratories, regulatory coordination, and clinical oversight.
Some costs can be significantly reduced -- or eliminated entirely -- through clinical trial enrollment, where treatment is often provided at no charge to qualifying patients. Outside of trials, the Jaime Leandro Foundation offers coordination services and limited financial assistance, and the FDA permits cost-recovery under 21 CFR 312.8 for expanded access programs. Medical financing options exist through healthcare lending providers, and some patients have successfully funded treatment through a combination of HSA funds, grants, and community fundraising.
Use the calculator below to model your estimated treatment costs based on the specific components of your care plan.
Foundation Medicine ~$5,800 | CeGaT CancerNeo ~$11,000 | Tempus ~$6,000
Bundled with sequencing at some providers (e.g., CeGaT)
mRNA vaccines tend toward lower end; peptide vaccines higher
7 doses over ~4 months. Varies by hospital and region
CT scans, blood draws, TCR tracking over 12-24 months
Individual patient IND application + physician coordination
Estimated Total Cost
$105,000
Estimated monthly payment
$2,219
60 months at 10% APR
Cost Breakdown
Estimates are approximate and vary by provider, location, and individual case. This is not a quote or financial guarantee. Always verify costs directly with your care team.
Provider & Approach Comparison
| Provider / Approach | Estimated Total | Timeline | Notes |
|---|---|---|---|
| CeGaT CancerNeo + partners | ~$100,000–$119,000 | 4–5 months | CeGaT covers sequencing + design (~$11K); manufacturing & admin coordinated separately |
| Jaime Leandro Foundation (JLF) | ~$92,000–$117,000 | 4–6 months | Nonprofit coordination, some financial aid |
| Clinical Trial (if eligible) | $0 (treatment covered) | Varies | Only for qualifying patients; limited slots |
| Academic Medical Center | Varies widely | 5–8 months | Mount Sinai, Dana-Farber, etc. Research-grade; pricing not publicly available |
Figures are estimates based on publicly available information and reported patient cases. Last updated March 2026.
How to Pay for Treatment
Personalized cancer vaccines are a significant financial commitment. These are the most common funding strategies patients use today.
Medical Loans
Healthcare lending providers like Prosper Healthcare Lending and CareCredit offer medical loans with fixed rates typically between 8-15% APR over 24-84 months. Some offer promotional 0% APR periods for qualified applicants.
Cancer Financial Assistance
Organizations like the Patient Advocate Foundation, CancerCare, and the Jaime Leandro Foundation provide grants, co-pay assistance, and logistical coordination. Some can cover portions of treatment or ancillary costs.
Clinical Trial Enrollment
If you qualify for a clinical trial, the investigational treatment is typically provided at no cost. Moderna/Merck (Phase 3), BioNTech (Phase 2), and several academic centers are actively recruiting patients.
HSA & FSA Accounts
If you have a Health Savings Account or Flexible Spending Account, investigational treatments may qualify for reimbursement. Consult your plan administrator and oncologist for documentation requirements.
Crowdfunding
GoFundMe medical campaigns raise an average of $10,000, with well-organized campaigns reaching $50,000+. Sharing a clear treatment plan with cost breakdown significantly improves results.
Combination Approach
Most patients combine multiple funding sources: a medical loan for the base, grants covering specific phases, HSA for eligible portions, and crowdfunding to close gaps. Planning early is critical.
Get a Detailed Cost Breakdown
Receive a personalized treatment cost summary in your inbox, including provider comparisons, financing options, and clinical trial alternatives.
Medical Disclaimer: Subscribing does not establish a doctor-patient relationship. ImmunaPath provides information and logistical support, not medical diagnosis or treatment.